Related Experiment Video
Updated: May 6, 2026

Isolating Brown Adipocytes from Murine Interscapular Brown Adipose Tissue for Gene and Protein Expression Analysis
Published on: March 12, 2021
PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
Erika Peverelli1, Federica Ermetici, Sabrina Corbetta
1Endocrinology and Diabetology UnitDepartment of Clinical Sciences and Community Health, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Pad.Granelli, Via F. Sforza, 35, 20122 Milan, Italy Diabetology and Metabolic Disease UnitIRCCS Policlinico San Donato, San Donato Milanese, Italy Endocrinology UnitIRCCS Policlinico S.Donato, Department of Biomedical Sciences for Health, University of Milan, Milan, Italy Unit of Human PathologyDepartment of Health Sciences, San Paolo Hospital Medical School, University of Milan, Milano, Italy Surgical DepartmentOspedale Sacra Famiglia Fatebenefratelli, Erba, Italy.
Abstract:
ADIPOGENESIS IS A COMPLEX PROCESS MODULATED BY SEVERAL FACTORS, INCLUDING CAMP SIGNALING. THE MAIN CAMP TARGET IS PROTEIN KINASE A (PKA), A TETRAMERIC ENZYME WITH FOUR REGULATORY SUBUNITS SHOWING TISSUE-SPECIFIC EXPRESSION AND FUNCTION: PRKAR2B is the main regulatory subunit in adipose tissue in mice and in adult humans. This study aimed to evaluate the expression of PKA regulatory subunits in human adipose tissue during fetal development and to investigate their role in the differentiation of 3T3-L1 and primary human preadipocytes. The expression of PKA regulatory subunits was evaluated in fetal adipose tissue (immunohistochemistry) and in cultured 3T3-L1 and primary human preadipocytes (western blot analysis). Cultured cells were transiently transfected with siRNA against PRKAR2B and induced to differentiate. Differentiation was evaluated by intracellular triglyceride staining (Oil Red O) and expression of molecular markers of adipocyte differentiation. In this study, we found that PRKAR2B is the main regulatory subunit in human adipose tissue during fetal development, from 12 weeks of gestation to the end of gestation, as well as in 3T3-L1 and primary human preadipocytes. The expression of PRKAR2B increases progressively during in vitro differentiation. The silencing of PRKAR2B abolishes the increase in the expression of peroxisome proliferator-activated receptor gamma (PPARγ (PPARG)), fatty acid synthase, aP2 (FABP4), and lipoprotein lipase, as well as intracellular triglyceride accumulation, resulting in impaired adipocyte differentiation in both mouse and human cell systems. In conclusion, PRKAR2B is the key PKA regulatory subunit involved in mouse and human adipose tissue development. The physiological increase in the expression of PRKAR2B is an essential event in adipogenesis in both mice and humans, and it might represent a possible target for future strategies for obesity treatment.
Insights
PRKAR2B is the key regulatory subunit for Protein Kinase A (PKA) in mouse and human adipose tissue development. Its increased expression is essential for adipogenesis and may offer a target for obesity treatments.
Area of Science:
- Molecular Biology
- Cell Biology
- Endocrinology
Background:
- Adipogenesis, the process of fat cell formation, is regulated by various factors, including cyclic adenosine monophosphate (cAMP) signaling.
- Protein Kinase A (PKA) is a primary target of cAMP signaling, playing a crucial role in cellular processes.
- PRKAR2B is identified as the predominant regulatory subunit of PKA in adipose tissue of mice and adult humans.
Purpose of the Study:
- To investigate the expression patterns of PKA regulatory subunits in human adipose tissue during fetal development.
- To elucidate the role of PRKAR2B in the differentiation of preadipocytes, using both cell line (3T3-L1) and primary human cells.
- To determine if PRKAR2B is essential for adipogenesis in mammalian systems.
Main Methods:
- Immunohistochemistry was used to assess PRKAR2B expression in fetal human adipose tissue.
- Western blot analysis was employed to evaluate PRKAR2B expression in cultured 3T3-L1 and primary human preadipocytes.
- RNA interference (siRNA) was utilized to silence PRKAR2B expression, followed by induction of differentiation and assessment of adipogenic markers.
Main Results:
- PRKAR2B was confirmed as the primary PKA regulatory subunit in human fetal adipose tissue (12 weeks gestation to term) and in preadipocyte models.
- PRKAR2B expression levels increased progressively during in vitro adipocyte differentiation.
- Silencing PRKAR2B significantly inhibited adipogenesis, evidenced by reduced triglyceride accumulation and suppressed expression of key adipogenic genes (PPARγ, FABP4, LPL).
Conclusions:
- PRKAR2B is a critical PKA regulatory subunit essential for adipogenesis in both mice and humans.
- The physiological upregulation of PRKAR2B during adipogenesis is a key event in fat tissue development.
- PRKAR2B represents a potential therapeutic target for modulating obesity.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
TGF - β Signaling Pathway
Master Transcription Regulators
The Ras Gene
Ras is a...
RNA Polymerase II Accessory Proteins

